Silco Pharmaceuticals Limited
  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Compliance Report
    • Dividend Disbursement Policy
    • Prospectus
    • Unpaid/Unclaimed Dividend
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us
Select Page

Price Sensitive Information (PSI)

PSI Year Ended 30 June, 2019

Brows From Here

PSI Year Ended 31 March, 2020

Brows From Here

PSI Year Ended 31 March, 2021

Brows From Here

PSI Year Ended 31st December, 2021

Brows From Here

PSI Year Ended 30 September, 2022

Brows From Here

PSI Year Ended 30 June, 2023

Brows From Here

PSI Period Ended 31st March 2024

Brows From Here

PSI Year Ended 30 September, 2019

Brows From Here

PSI New Export with Afghanistan

Brows From Here

PSI Year Ended 30 June, 2021

Brows From Here

PSI Year Ended 31st March, 2022

Brows From Here

PSI Year Ended 31st December, 2022

Brows From Here

PSI Year Ended 30 September, 2023

Brows From Here

PSI Half Year 31 December, 2019

Brows From Here

PSI Year Ended 30 June, 2020

Brows From Here

PSI Year Ended 30 September, 2021

Brows From Here

PSI Year Ended 30 June, 2022

Brows From Here

PSI Year Ended 31st March, 2023

Brows From Here

PSI Period Ended 31st December 2023

PSI Period Ended 31st December 2025

Brows From Here

Registered & Head Office

Nurani-41, Ban-Kalapara, Subid Bazar, Sylhet-3100, Bangladesh.

Phone: +8802996638241

E-mail:  info@silcopharma.com

 

 

 

 

 

 

 

 

 

 

 

 

 

ABOUT US

  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Compliance Report
    • Dividend Disbursement Policy
    • Prospectus
    • Unpaid/Unclaimed Dividend
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us

PRODUCTS

  • By Trade Name
  • By Generic Name
  • By Therapeutic Class

FACILITIES

  • Quality Policy
  • Manufacturing Facility
  • Quality Assurance
  • HVAC system
  • Cephalosporin Unit
  • Wastewater Treatment
  • Facebook
  • Twitter
  • Google
  • Youtube
  • RSS
© Silcopharma 2024 || Designed and Develop by Momi Technology LLC